Immutep Ltd, formerly Prima Biomed Ltd is a biotechnology company. It is engaged in the development of immunotherapeutic products for cancer and autoimmune disease. Their operations are based in Australia and Europe. This is an ADR of a company whose stock trades outside of the U.S. as the symbol AT:IMM.
$2.02 +0.01 (0.50%)
As of 06/30/2022 15:29:04 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.